Novel Multitarget Drug for Treating Diseases in Mammals (EP3632424A1)
Summary
The EPO published application EP3632424A1, filed by Pharmenterprises Eurasia LLC, covering a novel multitarget drug composition for treating diseases in mammals. Inventors listed are Nebolsin Vladimir Evgenievich, Kromova Tatyana Alexandrovna, and Rydlovskaya Anastasia Vladimirovna. The application carries IPC classifications including A61K 31/223 (amino acid derivatives) and is designated across 33 European states. Patent rights are enforceable upon grant, with the 18-month publication window providing third parties opportunity to review and oppose.
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 36 changes logged to date.
What changed
The EPO published patent application EP3632424A1 under the Pharmaceuticals regulatory area, designating protection across 33 European Contracting States. The application claims a novel multitarget drug composition using amino acid derivatives (A61K 31/223) for therapeutic use in mammals, with additional claims covering combination therapies under A61K 45/06.
Pharmaceutical manufacturers and drug developers should note this publication as it may represent prior art for competing drug development programs targeting similar therapeutic mechanisms. Third parties have the opportunity to submit observations during the examination phase. The designated states include major pharmaceutical markets including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL MULTITARGET DRUG FOR TREATING DISEASES IN MAMMALS
Publication EP3632424A1 Kind: A1 Apr 15, 2026
Applicants
"Pharmenterprises Eurasia"
Limited Liability Company
Inventors
NEBOLSIN, Vladimir Evgenievich, KROMOVA, Tatyana Alexandrovna, RYDLOVSKAYA, Anastasia Vladimirovna
IPC Classifications
A61K 31/223 20060101AFI20210126BHEP A61K 45/06 20060101ALI20210126BHEP A61P 1/00 20060101ALI20210126BHEP A61P 1/12 20060101ALI20210126BHEP A61P 1/08 20060101ALI20210126BHEP A61P 3/04 20060101ALI20210126BHEP A61P 17/06 20060101ALI20210126BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.